Organicell Regenerative Medicine (OTCMKTS:BPSR) Stock Price Breaks Above Fifty Day Moving Average – Here’s Why

Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR)’s stock price passed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $1.25 and traded as high as $1.3668. Organicell Regenerative Medicine shares last traded at $1.36, with a volume of 7,684 shares trading hands.

Organicell Regenerative Medicine Price Performance

The business’s 50 day moving average is $1.25 and its 200 day moving average is $1.81.

About Organicell Regenerative Medicine

Organicell Regenerative Medicine, Inc is a biotechnology company focused on developing regenerative medicine products designed to support tissue repair and modulate inflammatory and immune responses. The company’s research centers on biologic therapies derived from human amniotic fluid and other perinatal sources.

Its principal product candidate is Zofin, an acellular biologic containing extracellular vesicles and other naturally occurring components found in amniotic fluid. Organicell has investigated Zofin for potential applications involving inflammation, immune-system regulation, and tissue regeneration, including research related to respiratory and other systemic conditions.

Organicell’s products remain under development, and investigational uses should not be interpreted as evidence of regulatory approval or established clinical effectiveness.